Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL008507-01
Application #
3051879
Study Section
Clinical Trials (CLIN)
Project Start
1991-12-20
Project End
Budget Start
1991-07-15
Budget End
1992-07-14
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Weyrich, A S; Buerke, M; Albertine, K H et al. (1995) Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol 57:45-55
Buerke, M; Weyrich, A S; Lefer, A M (1994) Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. Am J Physiol 266:H128-36
Albertine, K H; Weyrich, A S; Ma, X L et al. (1994) Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J Leukoc Biol 55:557-66
Weyrich, A S; Ma, X L; Buerke, M et al. (1994) Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75:692-700
Ma, X L; Weyrich, A S; Lefer, D J et al. (1993) Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 88:649-58
Ma, X L; Weyrich, A S; Lefer, D J et al. (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72:403-12
Ma, X L; Weyrich, A S; Krantz, S et al. (1992) Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. J Pharmacol Exp Ther 260:1229-36
Weyrich, A S; Ma, X L; Lefer, A M (1992) The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86:279-88